Home
About
Prosetta Strategy Management Board of Directors Advisory Board
Science
Prosetta's Science The Prosetta Platform Publications
Programs
ALS Program Pan Respiratory Program Oncology Program Parkinson's Program HIV Program Rabies Program Exploratory Applications
News
Careers
Contact

Prosetta Biosciences

Home
About
Prosetta Strategy Management Board of Directors Advisory Board
Science
Prosetta's Science The Prosetta Platform Publications
Programs
ALS Program Pan Respiratory Program Oncology Program Parkinson's Program HIV Program Rabies Program Exploratory Applications
News
Careers
Contact

Takeda to Study Prosetta Biosciences' CNS Compounds

Takeda Pharmaceutical will partner with Prosetta Biosciences on a feasibility study for possible future co-development of Prosetta’s novel compounds for diseases and disorders of the central nervous system. Read more here.

Source: http://www.genengnews.com/gen-news-highlig...
Newer:Prosetta gets a mention in Nature MedicineOlder:Prosetta Biosciences, Inc. Announces Closing of Private Placement
PostedMay 2, 2016
AuthorProsetta

©2016 Prosetta Biosciences, Inc.